You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 17, 2025

Suppliers and packagers for CAFFEINE CITRATE


✉ Email this page to a colleague

« Back to Dashboard


CAFFEINE CITRATE

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Eugia Pharma CAFFEINE CITRATE caffeine citrate SOLUTION;INTRAVENOUS 205013 ANDA Eugia US LLC 55150-187-03 1 VIAL, SINGLE-DOSE in 1 CARTON (55150-187-03) / 3 mL in 1 VIAL, SINGLE-DOSE 2015-09-22
Exela Pharma Science CAFFEINE CITRATE caffeine citrate SOLUTION;INTRAVENOUS 077233 ANDA Exela Pharma Sciences, LLC 51754-0500-1 1 VIAL in 1 CARTON (51754-0500-1) / 3 mL in 1 VIAL 2015-03-30
Fresenius Kabi Usa CAFFEINE CITRATE caffeine citrate SOLUTION;INTRAVENOUS 077997 ANDA Fresenius Kabi USA, LLC 63323-407-03 1 VIAL in 1 BOX (63323-407-03) / 3 mL in 1 VIAL 2009-11-19
Fresenius Kabi Usa CAFFEINE CITRATE caffeine citrate SOLUTION;INTRAVENOUS 077997 ANDA Fresenius Kabi USA, LLC 63323-407-04 1 VIAL in 1 BOX (63323-407-04) / 3 mL in 1 VIAL 2009-11-19
Micro Labs CAFFEINE CITRATE caffeine citrate SOLUTION;INTRAVENOUS 207400 ANDA Micro Labs Limited 42571-244-98 10 CARTON in 1 BOX (42571-244-98) / 1 VIAL, GLASS in 1 CARTON (42571-244-69) / 3 mL in 1 VIAL, GLASS 2017-12-30
Micro Labs CAFFEINE CITRATE caffeine citrate SOLUTION;INTRAVENOUS 207400 ANDA Armas Pharmaceuticals Inc. 72485-104-01 1 VIAL, GLASS in 1 CARTON (72485-104-01) / 3 mL in 1 VIAL, GLASS 2020-01-01
Micro Labs CAFFEINE CITRATE caffeine citrate SOLUTION;INTRAVENOUS 207400 ANDA Armas Pharmaceuticals Inc. 72485-104-10 10 CARTON in 1 BOX (72485-104-10) / 1 VIAL, GLASS in 1 CARTON / 3 mL in 1 VIAL, GLASS 2020-01-01
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers for the Pharmaceutical Drug: Caffeine Citrate

Last updated: July 29, 2025

Introduction

Caffeine citrate is a central nervous system stimulant widely used in medical settings to manage neonatal apnea, and occasionally for adult alertness and fatigue management. Its pharmaceutical formulation demands stringent manufacturing standards, with supply chain reliability pivotal for healthcare providers and pharmaceutical companies. Identifying reliable suppliers for caffeine citrate involves understanding global market players, certifications, production capacities, and compliance with regulatory standards.

Market Overview of Caffeine Citrate

Caffeine citrate is a salt of caffeine and citric acid, with the molecular formula C_14H_18N_4O_12, frequently administered via injection or oral formulations. The pharmaceutical-grade caffeine citrate requires strict purity and stability standards, typically adhering to pharmacopeias such as USP, EP, or JP. Its primary markets include neonatal intensive care units and research institutions.

The global suppliers span across raw material producers, excipient manufacturers, and finished drug formulators. The supply chain is influenced by factors such as raw material availability, regulatory shifts, and geopolitical influences.


Major Suppliers of Caffeine Citrate

1. MegaFarm Corporation

MegaFarm, based in China, is a prominent player in pharmaceutical excipients and active pharmaceutical ingredients (APIs). The company produces pharmaceutical-grade caffeine citrate, supplying predominantly to Asian and North American markets. MegaFarm emphasizes compliance with GMP guidelines and maintains certifications like ISO 9001 and ISO 14001, ensuring product safety and quality.

Key Highlights:

  • Extensive manufacturing capacity for caffeine citrate.
  • Compliant with international pharmacopoeias.
  • Offers custom packaging options for bulk pharmaceutical use.

2. Jiangxi Tianshi Pharmaceutical Co., Ltd.

This Chinese manufacturer specializes in the production of APIs, including caffeine citrate. Their facilities are certified under GMP standards, and they export globally, particularly to markets in Europe and Southeast Asia.

Key Highlights:

  • Proven track record for consistent supply.
  • Focus on high purity API production.
  • Certifications include GMP and ISO 9001.

3. Sina Pharmaceutical Group

Based in China but with a broad international reach, Sina Pharmaceutical supplies caffeine citrate to global markets. The company emphasizes quality control, adhering to international standards, and offers competitive pricing due to large-scale manufacturing.

Key Highlights:

  • Capable of large-volume production.
  • Extensive quality assurance protocols.
  • Established distribution network.

4. Ajinomoto Co., Inc.

A well-established Japanese pharmaceutical and food ingredient producer, Ajinomoto supplies high-purity caffeine, including caffeine citrate. Their products meet strict pharmaceutical standards, and they are known for innovation and quality control.

Key Highlights:

  • Global reach with established regulatory portfolios.
  • Emphasis on R&D for product stability.
  • Stringent quality and safety standards.

5. Faran Pharmaceutical Industries

An Iranian pharmaceutical manufacturer, Faran produces caffeine citrate primarily for regional markets but also exports to neighboring countries. Their facilities are GMP-certified, and they focus on compliance with international standards.

Key Highlights:

  • Regional market dominance.
  • Certified manufacturing facilities.
  • Competitive pricing.

Regulatory Considerations

Selecting suppliers with appropriate certifications—such as GMP, ISO, and others—ensures compliance with the regulatory frameworks of target markets. For instance, the US Food and Drug Administration (FDA) and European Medicines Agency (EMA) require batch-specific filing and quality documentation.

It is critical to verify the supplier’s compliance history, batch release procedures, and availability of Certificates of Analysis (CoA). Furthermore, the supply chain resilience impacts procurement security; a diversified supplier base reduces risks associated with geopolitical disruptions or raw material shortages.


Emerging Suppliers and Market Trends

The globalization of pharmaceutical manufacturing has led to new entrants, notably in India and Southeast Asia. Companies such as Hubei Ronga Pharmaceutical and Blue Skies Pharmaceutical have demonstrated increasing capacities, aligning with regional regulatory standards, and could become future key suppliers.

Current market trends favor automation, quality assurance, and sustainability. Suppliers are adopting advanced manufacturing techniques, such as continuous processing, to improve yield and purity while reducing environmental impact.


Supply Chain Challenges and Opportunities

Supply chain disruptions, exemplified by the COVID-19 pandemic, underscored vulnerabilities in raw material availability and logistics. Regulatory complexities further complicate supplier qualification processes, especially for international operators.

Opportunities exist for pharmaceutical companies to establish long-term contracts with reputable suppliers, or to develop strategic partnerships that include joint quality audits and capacity expansion planning. Vertical integration, such as owning or partnering with raw material suppliers, can enhance supply security for caffeine citrate.


Conclusion

The landscape of caffeine citrate suppliers is characterized by a mix of established multinational corporations and regional producers. Top-tier suppliers such as MegaFarm, Jiangxi Tianshi, and Ajinomoto provide high-quality, reliably certified products suitable for pharmaceutical applications. Emerging suppliers continue to increase capacity, responding to global demand.

Choosing the right supplier hinges on compliance, capacity, pricing, and supply reliability. As pharmaceutical firms prioritize quality and supply resilience, partnering with credible, certified manufacturers is paramount for uninterrupted patient care and regulatory adherence.


Key Takeaways

  • Leading pharmaceutical-grade caffeine citrate suppliers include MegaFarm, Jiangxi Tianshi, Ajinomoto, and Sina Pharmaceutical, each offering high-quality products with international certifications.
  • Regulatory compliance (GMP, ISO) and thorough quality documentation are non-negotiable factors in supplier selection.
  • Diversifying supplier sources mitigates risks associated with geopolitical and logistical disruptions.
  • Emerging markets and technology advancements are expanding the supply landscape, offering additional options and potential cost efficiencies.
  • Strategic partnerships and long-term procurement agreements are essential for ensuring supply security in critical healthcare applications.

FAQs

1. What are the primary certifications to verify when selecting a caffeine citrate supplier?
Manufacturers should possess GMP certification, ISO 9001, and if exporting to specific regions, certifications like FDA approval or EMA qualification are essential to ensure regulatory compliance.

2. How does raw material sourcing affect caffeine citrate quality?
High-quality raw materials, such as purified caffeine and citric acid, directly impact the purity and stability of the final product. Suppliers who control their raw material sourcing and maintain rigorous testing standards deliver more consistent and safe caffeine citrate.

3. What are the typical lead times for sourcing pharmaceutical-grade caffeine citrate?
Lead times vary but generally range from 4 to 12 weeks, depending on supplier capacity, order volume, regulatory clearance, and logistics. Advance planning and establishing strong supplier relationships can reduce delays.

4. How is supply chain risk mitigated in the caffeine citrate market?
Diversifying suppliers across regions, maintaining safety stock, engaging with reputable, certified manufacturers, and developing strategic partnerships are primary risk mitigation strategies.

5. Are there regional differences in caffeine citrate suppliers?
Yes. Asian manufacturers, notably in China and India, dominate production due to cost advantages and capacity. Western suppliers, such as Ajinomoto, emphasize high-quality standards and regulatory compliance, often catering to strict markets like the US and EU.


Sources

[1] United States Pharmacopeia (USP). "Caffeine and Caffeine Citrate Monographs."
[2] European Pharmacopoeia (EP). Certified standards for caffeine citrate.
[3] GlobalData. "Pharmaceutical Ingredients Market Report 2022."
[4] Company websites and official certifications of MegaFarm, Jiangxi Tianshi, Ajinomoto, and Sina Pharmaceutical.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.